Fady Ibraham Malik - 18 Aug 2026 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Reporting relationship: EVP Research & Development
Issuer ticker: CYTK
Reported as of: 18 Aug 2026
Net transaction value: -$265,370
SEC form: 4
Accepted by SEC: 18 Aug 2026, 16:38:26 UTC
Prior SEC filing: 23 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ John O. Faurescu, attorney-in-fact for Dr. Malik

Key filing fact

Fady Ibraham Malik filed Form 4 for CYTOKINETICS INC (CYTK) on 18 Aug 2026.

Key facts

This page summarizes Fady Ibraham Malik's Form 4 filing for CYTOKINETICS INC (CYTK).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Aug 2026, 16:38.

Change

Previous filing in this sequence was filed on 23 Jul 2026.
Current net transaction value: -$265,370.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001551778 Primary reporting owner

Malik Fady Ibraham

Relationship: EVP Research & Development
Address: 350 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Signature: /s/ John O. Faurescu, attorney-in-fact for Dr. Malik
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYTK transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,500
Change %: +2.3%
Price: $7.80^*
Shares after: 157,402
Date: 18 Aug 2026
Ownership: Direct

CYTK transaction

Common Stock

Sale

Transaction value: $265,370
Shares: -3,500
Change %: -2.2%
Price: $75.82
Shares after: 153,902
Date: 18 Aug 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYTK transaction Derivative

Non-Qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -3,500
Change %: -10%
Price: $0.000000^*
Shares after: 30,386
Date: 18 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,500
Exercise price: $7.80

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).